Drug Shortage Report for PMS-TOPOTECAN
Report ID | 1969 |
Drug Identification Number | 02406446 |
Brand name | PMS-TOPOTECAN |
Common or Proper name | Topotecan |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | TOPOTECAN |
Strength(s) | 4MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2015-07-20 |
Estimated end date | Unknown |
Actual end date | 2020-04-01 |
Shortage status | Resolved |
Updated date | 2020-04-02 |
Company comments | Product to be discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-04-02 | French | Compare |
v9 | 2020-04-02 | English | Compare |
v8 | 2019-01-16 | French | Compare |
v7 | 2019-01-16 | English | Compare |
v6 | 2019-01-16 | French | Compare |
v5 | 2019-01-16 | English | Compare |
v4 | 2017-03-13 | French | Compare |
v3 | 2017-03-13 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 10 of 10